China News Service, January 16. According to news from the website of the State Food and Drug Administration on the 16th, in order to thoroughly implement the relevant requirements of the Central Leading Group for Epidemic Response and the Joint Prevention and Control Mechanism of the State Council on epidemic prevention and control, and effectively ensure the quality and safety of public medication, the new crown epidemic Since then, the State Food and Drug Administration has deployed local drug regulatory departments to continue to strengthen the quality supervision of medical devices related to epidemic prevention and control, and increase the crackdown on illegal and criminal activities related to the manufacture and sale of epidemic-related medical devices.

  Among them, in response to the recent clues of illegal sales of drugs for the treatment of new coronavirus infection with unknown sources in the market, the drug regulatory authorities in many places have adopted a combination of online monitoring and offline investigation to innovate regulatory ideas, dig deep into the source of the case, and strictly investigate violations. .

Under the unified command, the local drug regulatory department and the local public security department jointly enforced the law, and some criminal gangs and dens have been destroyed, and a batch of counterfeit Paxlovid (Nimatevir/ritonavir tablet combination) was seized on the spot during the network collection operation packaging) and unapproved imported drugs, etc.

After inspection, some of the seized products did not contain effective pharmaceutical ingredients or were illegally added with other pharmaceutical ingredients, suspected of violating the provisions of Article 141 of the Criminal Law of the People's Republic of China on the crime of selling counterfeit medicines.

At present, the case is being handled by the public security department according to law.

  In order to thoroughly investigate risks, eliminate hidden dangers, and effectively protect the public's drug demand and drug safety, the State Food and Drug Administration has organized national drug regulatory agencies to further increase the monitoring, investigation, inspection, and case investigation of the production and sale of counterfeit new coronavirus infection treatment drugs. If a suspected crime is discovered, it shall be transferred to the public security and judicial organs according to law.

At the same time, the State Food and Drug Administration is promoting the development and marketing of new coronavirus therapeutic drugs in accordance with laws and regulations to serve the overall situation of epidemic prevention and control.